After a year-long review, Australia national medical research body advises conditional puberty blockers for transgender children

Guidance on puberty blockers
The National Health and Medical Research Council (NHMRC), an independent statutory agency funded by the Commonwealth, says puberty blockers can be appropriate for children in certain circumstances. The advice followed a year-long review of international evidence.
The council says treatment for gender incongruence does not require a child to be distressed. It recommends that decisions about a multidisciplinary team be made case by case.
Puberty blockers have been used to treat conditions including precocious puberty since the 1970s, and in gender-affirming care since the 1990s. The guidelines describe gender incongruence as a difference between a person’s gender and their sex recorded at birth.
Council rejects wait and see
The NHMRC rejected alternatives proposed by opponents of gender-affirming care, including a “wait and see” model. It said withholding care can affect a young person’s physical and mental health, wellbeing and ability to function.
The council noted that some young people with gender incongruence experience significant distress, known as gender dysphoria. It also said trans and gender-diverse young people face avoidable health disparities linked to stigma, discrimination and barriers to healthcare.
Other guidance still to come
The new recommendations are at odds with public hospital bans in Queensland and the Northern Territory. The article also says the New Zealand government later followed suit, despite opposition in the health sector and warnings that bans would harm children.
The full NHMRC guidelines are expected in 2028 and will cover other aspects of care, including gender-affirming hormones. Hormone replacement therapy uses synthetic hormones to replace those produced by the body and is used for conditions including some cancers, endometriosis and gender incongruence.
Key points
- The NHMRC says puberty blockers may be suitable for children in certain circumstances.
- The council rejects a “wait and see” approach as potentially withholding care.
- The guidance differs from public hospital bans in Queensland and the Northern Territory.
- Full guidelines, including advice on gender-affirming hormones, are expected in 2028.

